Vascular dementia: prevention and treatment

(2211) Views  (433) Full article downloads

Authors: Catherine McVeigh, Peter Passmore

Published Date January 2006 Volume 2006:1(3) Pages 229 - 235

DOI: http://dx.doi.org/10.2147/CIA.S

Catherine McVeigh, Peter Passmore

Department of Geriatric Medicine, Faculty of Medicine and Health Sciences, Queen’s University of Belfast, Belfast, Northern Ireland, UK

Background: Vascular dementia (VaD) is the most common cause of dementia in the elderly, second only to Alzheimer’s disease (AD). Between 1% and 4% of people of 65 years of age suffer from VaD and the prevalence appears to double every 5–10 years after the age of 65.

Summary: Prevention aims to reduce the disease by eliminating its cause or main risk factors, particularly hypertension as well as diabetes mellitus, atherosclerosis, coronary artery disease, smoking, lipid abnormalities, and hyperhomocystinemia. Initial studies of several agents for symptomatic treatment were disappointing. However, there is growing evidence for cholinergic involvement in VaD and recent studies with cholinesterase inhibitors have shown improvement in cognitive, global function, and activities of daily living as compared with placebo and have been well tolerated.

Conclusion: VaD is a common condition and its prevalence is likely to increase. As physicians we need to be diligent with regards to recognition of risk factors and vigorous intervention. Promising results have been seen in several clinical trials of cholinesterase inhibitors and no safety of tolerability issues have been noted.

Keywords: vascular dementia, prevention, treatment